Sign in

You're signed outSign in or to get full access.

GLOBE LIFE (GL)

--

Earnings summaries and quarterly performance for GLOBE LIFE.

Research analysts who have asked questions during GLOBE LIFE earnings calls.

AK

Andrew Kligerman

TD Cowen

10 questions for GL

Also covers: ABL, ACGL, AJG +21 more
JB

John Barnidge

Piper Sandler

10 questions for GL

Also covers: AFL, AIZ, AMP +15 more
EG

Elyse Greenspan

Wells Fargo

8 questions for GL

Also covers: ACGL, AFL, AHL +30 more
Suneet Kamath

Suneet Kamath

Jefferies

8 questions for GL

Also covers: AFL, AMP, BHF +12 more
TG

Thomas Gallagher

Evercore

8 questions for GL

Also covers: AFL, AMP, BHF +13 more
WC

Wesley Carmichael

Autonomous Research

8 questions for GL

Also covers: ACGL, AFL, BHF +16 more
JB

Jimmy Bhullar

JPMorgan Chase & Co.

7 questions for GL

Also covers: ACGL, AFL, ALL +12 more
Ryan Krueger

Ryan Krueger

KBW

7 questions for GL

Also covers: AFL, AMP, ASGN +14 more
Jack Matten

Jack Matten

BMO Capital Markets

5 questions for GL

Also covers: AFL, CNO, EQH +6 more
MH

Mark Hughes

Truist Securities

5 questions for GL

Also covers: AIZ, AJG, AMBC +41 more
Wilma Burdis

Wilma Burdis

Raymond James Financial

5 questions for GL

Also covers: AFL, ALTI, AMP +16 more
JB

Jamminder Bhullar

JPMorgan Chase & Co.

3 questions for GL

Also covers: ACGL, AFL, ALL +13 more
Wilma Jackson Burdis

Wilma Jackson Burdis

Raymond James

3 questions for GL

Also covers: AFL, ALTI, AMP +12 more
FM

Francis Matten

BMO Capital Markets

2 questions for GL

Also covers: AFL, CNO, CRBG +6 more
JS

Jeff Schmitt

William Blair & Company, L.L.C.

2 questions for GL

Also covers: AIZ, AMP, FRGE +9 more
Joel Hurwitz

Joel Hurwitz

Dowling & Partners Securities, LLC

2 questions for GL

Also covers: AFL, CNO, CRBG +9 more
MF

Maxwell Fritscher

Truist Financial Corporation

2 questions for GL

Also covers: BXSL, EQH, FSK +10 more
WC

Wes Carmichael

Wells Fargo & Company

2 questions for GL

Recent press releases and 8-K filings for GL.

Globe Life reports Q4 2025 results
GL
Earnings
Guidance Update
Share Buyback
  • In Q4 2025, net income was $266 million ($3.29 per share) and net operating income was $274 million ($3.39 per share), up 8% YoY; full-year net operating income was $14.52 per share, GAAP ROE 20.9% (16% ex-AOCI), and book value per share $96.16 ex-AOCI (+11% YoY).
  • Fourth-quarter total premium revenue grew 5%, with life premiums of $850 million (+3%) and life underwriting margin $350 million (+4%), and health premiums of $392 million (+9%) and health underwriting margin $99 million (+9%).
  • 2026 guidance: total premium growth of 7–8% (life 4–4.5%, health 14–16%), underwriting margins of 41.5–44.5% (life) and 23–27% (health), and net operating EPS of $14.95–$15.65 (+5% at midpoint).
  • Net investment income was $281 million (flat) and excess investment income $31 million (down $8 million); invested assets totaled $21.7 billion with a 5.4% yield. 2026 planned investments: $900 M–$1.1 B in fixed maturities (avg. 5.9–6.0%) and $300 M–$400 M in non-fixed maturities (7–9%) for a blended 5.4–5.5% yield.
  • In 2025, Globe Life repurchased 5.4 million shares for $685 million, parent excess cash flow was $620 million, with 2026 projections of $625–675 million (dividends $85–90 million; buybacks $535–585 million); also formed Globe Life Re Ltd. and reinsured $1.2 billion of reserves to Bermuda.
1 day ago
Globe Life reports Q4 2025 results
GL
Earnings
Guidance Update
Share Buyback
  • Globe Life reported Q4 2025 net income of $266 million ($3.29/share) and net operating income of $274 million ($3.39/share); full-year 2025 ROE was 20.9% with book value per share of $74.17 (ex-AOCI $96.16).
  • Total Q4 premium revenue grew 5%, with life premiums of $850 million (+3%) and a life underwriting margin of $350 million (+4%), and health premiums of $392 million (+9%) with a health underwriting margin of $99 million (+9%).
  • 2026 guidance includes net operating EPS of $14.95–$15.65 (5% growth at midpoint); total premium growth of 7–8% (life 4–4.5%, health 14–16%); and expected underwriting margins of 41.5–44.5% (life) and 23–27% (health).
  • Returned approximately $770 million to shareholders in 2025 via 5.4 million share repurchases (costing $685 million) and $85 million in dividends; Q4 buybacks were 1.3 million shares for $170 million.
1 day ago
Globe Life reports Q4 2025 results
GL
Earnings
Guidance Update
Share Buyback
  • In Q4 the company generated $266 M in net income ( $3.29 EPS vs. $255 M or $3.01 EPS a year ago) and $274 M net operating income ( $3.39 EPS, +8% YoY); FY 2025 net operating income was $14.52 per share, GAAP ROE 20.9%, book value $74.17 per share.
  • Insurance operations saw Q4 life premiums of $850 M (+3%) with life underwriting margin of $350 M (+4%), and Q4 health premiums of $392 M (+9%) with health underwriting margin of $99 M (+9%); 2026 guidance calls for 7–8% total premium growth (life 4–4.5%, health 14–16%) with margins of 41.5–44.5% (life) and 23–27% (health).
  • Investment income in Q4 was $281 M (flat YoY) with $31 M excess investment income (down $8 M); fixed maturities yielded 5.29%, blended earned yield 5.4%, and invested assets totaled $21.7 B; 2026 net investment income is expected to grow 3–4%, required interest ~4%, and excess investment income flat.
  • The parent repurchased 1.3 M shares for $170 M in Q4 and 5.4 M shares for $685 M in 2025, paid $85 M in dividends, returning $770 M to shareholders; ended 2025 with $80 M in liquid assets; 2026 excess cash flow is guided to $625–675 M, primarily for dividends ($85–90 M) and buybacks.
  • For 2026 the company forecasts $14.95–$15.65 net operating EPS (≈5% growth) and normalized EPS growth of ~10%.
1 day ago
Globe Life reports Q4 and full-year 2025 results
GL
Earnings
Share Buyback
Guidance Update
  • In Q4 2025, Globe Life reported $3.29 per diluted share in net income (up from $3.01) and for the full year achieved $14.07 per diluted share in net income and $14.52 in net operating income, both up 8% YoY.
  • The company repurchased 1.3 million shares in Q4 for $170 million (average $134.44), totaling 5.4 million shares for $685 million in 2025.
  • For 2026, Globe Life increased its guidance to $14.95–$15.65 per diluted share in net operating income.
2 days ago
Globe Life reports Q4 2025 earnings
GL
Earnings
Share Buyback
Guidance Update
  • Globe Life delivered Q4 net operating income of $3.39 per diluted share (up 8% y/y) and net income of $3.29 per diluted share (up 9% y/y).
  • For full-year 2025, net operating income was $14.52 and net income was $14.07 per diluted share (both up 8%), with ROE of 20.9%.
  • Q4 insurance underwriting income rose 6% to $359.7 million on total premium revenue of $1.242 billion (up 5%) driven by higher life and health sales.
  • The company repurchased 1.3 million shares for $170 million in Q4 (5.4 million shares for $685 million in 2025) and is guiding 2026 net operating income of $14.95–$15.65 per diluted share.
2 days ago
Globe Life forms Bermuda reinsurance affiliate
GL
New Projects/Investments
  • Globe Life Re Ltd. has been formed and licensed as a Bermuda Class C insurer to provide reinsurance support for Globe Life’s affiliate entities.
  • The new affiliate will underwrite affiliated quota share reinsurance, assuming a proportional share of risk on specified insurance policies.
  • Globe Life Re Ltd. has executed its first reinsurance transaction in line with its business plan.
  • Globe Life Inc. is headquartered in McKinney, TX, employs over 16,000 agents and 3,600 corporate staff, and has more than 17 million policies in force.
Dec 23, 2025, 11:04 PM
Globe Life credit ratings affirmed by AM Best
GL
  • AM Best affirmed the Financial Strength Rating of A (Excellent) and Long-Term Issuer Credit Rating of A+ (Excellent) for Globe Life’s life/health subsidiaries, and BBB+ (Good) for Globe Life Inc., all with a stable outlook.
  • The affirmations reflect Globe Life’s strong balance sheet, very strong operating performance, favorable business profile, and robust enterprise risk management framework.
  • On a statutory basis, year-end 2024 capital and surplus increased, and investment income exceeded $1 billion, driven by improved bond net yields.
  • Key debt ratings affirmed include BBB+ on $550 million 4.55% senior unsecured notes due 2028 and $400 million 2.15% notes due 2030, among other senior and subordinated instruments.
Nov 12, 2025, 8:14 PM
Globe Life reports Q3 2025 results
GL
Earnings
Share Buyback
Guidance Update
  • Globe Life delivered $4.73 net income per diluted share (YoY +38%) and $4.81 net operating income per share (YoY +38%) for Q3 2025.
  • Life underwriting margin rose 24% to $481.6 M and health underwriting margin increased 25% to $108.4 M in Q3 2025.
  • Divisional performance included +5% life premiums at American Income Life & Liberty National, +13% health net sales and +10% health premiums at Family Heritage, and +13% life net sales at Direct to Consumer.
  • Repurchased 840,242 shares at a total cost of $113 M, and raised 2025 net operating income per share guidance to $14.40–$14.60 (2026: $14.60–$15.30).
Oct 22, 2025, 8:10 PM
Globe Life closes Department of Justice investigation
GL
Legal Proceedings
  • The U.S. Attorney’s Office for the Western District of Pennsylvania has closed its investigation into Globe Life and American Income Life, with no enforcement action to be taken.
  • The probe stemmed from subpoenas concerning sales practices by independent agents selling AIL policies.
  • Globe Life, headquartered in McKinney, TX, employs 16,000 insurance agents, 3,600 corporate staff, and has over 17 million policies in force.
Jul 28, 2025, 9:47 PM
Globe Life reports Q2 2025 results
GL
Earnings
Guidance Update
Share Buyback
  • Globe Life posted net operating income of $271 million (​$3.27/share), a 10% increase year-over-year, and GAAP net income of $253 million (​$3.50/share), with GAAP ROE of 18.8% and ex-AOCI ROE of 14.4% as of June 30.
  • Q2 life premium revenue grew 3% to $840 million with a 6% rise in life underwriting margin to $340 million, while health premium revenue rose 8% to $378 million but health underwriting margin declined 2% to $98 million; full-year guidance: life premium +3.5%, life margin 43–45% of premium, health premium +8–9%, health margin 25–27% of premium.
  • Distribution remains strong: average total agent count increased 6% sequentially to 17,621 agents, underpinned by robust recruiting and onboarding across exclusive agencies.
  • Capital return: repurchased 1.9 million shares for $226 million at an average price of $121.13 and paid $22 million in dividends in Q2, totaling ~$250 million returned; full-year plan includes $600–650 million in buybacks and $80–90 million in dividends; parent liquidity ended Q2 at $105 million, and a $500 million 30-year contingent capital facility was secured.
  • Submitted preliminary plan to Bermuda Monetary Authority to launch a reinsurance affiliate by year-end, aiming to cede up to 25% of statutory life reserves over time, with potential to unlock incremental annual cash flow of $200 million by 2027.
Jul 24, 2025, 8:10 PM